← FDA Drug Approvals (Drugs@FDA)
LOTEMAX
NDA · New Drug Application · Sponsor: BAUSCH AND LOMB INC · Approved 2012-09-28
Drug application
- FDA Application #
NDA202872- Application type
- New Drug Application
- Brand name
- LOTEMAX
- Generic name
- LOTEPREDNOL ETABONATE
- Active ingredients
- LOTEPREDNOL ETABONATE
- Dosage form
- GEL
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- BAUSCH AND LOMB INC
- Manufacturer
- Bausch & Lomb Incorporated
- First approval
- 2012-09-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown